EcoDrugPlus

Beta-Secretase 1

Ensembl ID : ENSACLG00000011176
Gene Symbol: BACE1
3 Cross references
221 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSACLG00000014100
Gene Symbol: BDKRB2
3 Cross references
217 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSACLG00000014114
Gene Symbol: BDKRB2
2 Cross references
151 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSACLG00000014119
Gene Symbol: BDKRB2
4 Cross references
182 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSACLG00000014034
Gene Symbol: BDKRB2
2 Cross references
217 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSACLG00000014047
Gene Symbol: BDKRB2
3 Cross references
220 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSACLG00000013997
Gene Symbol: BDKRB2
1 Cross references
219 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSACLG00000014077
Gene Symbol: BDKRB2
2 Cross references
216 Possible Orthologues:

Breakpoint Cluster Region Protein-Like

Ensembl ID : ENSACLG00000001482
Gene Symbol: LOC113033125
3 Cross references
203 Possible Orthologues:

Camp-Specific 3',5'-Cyclic Phosphodiesterase 4c-Like

Ensembl ID : ENSACLG00000005032
Gene Symbol: LOC113024511
3 Cross references
173 Possible Orthologues:

Calcium Channel, Voltage-Dependent, L Type, Alpha 1c Subunit

Ensembl ID : ENSACLG00000025255
Gene Symbol: CACNA1C
1 Cross references
215 Possible Orthologues:

Calcium Channel, Voltage-Dependent, L Type, Alpha 1s Subunit, B

Ensembl ID : ENSACLG00000004840
Gene Symbol: CACNA1SB
1 Cross references
196 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).